Technical Analysis for SAVA - Cassava Sciences, Inc.

Grade Last Price % Change Price Change
grade A 9.7 -0.61% -0.06
SAVA closed down 6.6 percent on Wednesday, September 23, 2020, on 78 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up
Historical SAVA trend table...

Date Alert Name Type % Chg
Slingshot Bullish Bullish Swing Setup -0.61%
Upper Bollinger Band Walk Strength -0.61%
Multiple of Ten Bearish Other -0.61%
Wide Bands Range Expansion -0.61%
Overbought Stochastic Strength -0.61%
New 52 Week Closing High Bullish -7.18%
New 52 Week High Strength -7.18%
Parabolic Rise Strength -7.18%
Upper Bollinger Band Walk Strength -7.18%
Multiple of Ten Bullish Other -7.18%
Older End-of-Day Gignals for SAVA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 1% about 2 hours ago
60 Minute Opening Range Breakout about 2 hours ago
Gap Down Closed about 2 hours ago
Reversed from Down about 2 hours ago
Fell Below Previous Day's Low about 4 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
Biology Pain Alzheimer's Disease Neuroscience Mental Health Psychiatric Diagnosis Psychiatry

Is SAVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.25
52 Week Low 1.1
Average Volume 8,005,202
200-Day Moving Average 4.88
50-Day Moving Average 4.09
20-Day Moving Average 5.32
10-Day Moving Average 7.54
Average True Range 0.96
ADX 50.81
+DI 53.67
-DI 7.62
Chandelier Exit (Long, 3 ATRs ) 8.36
Chandelier Exit (Short, 3 ATRs ) 5.67
Upper Bollinger Band 11.01
Lower Bollinger Band -0.36
Percent B (%b) 0.89
BandWidth 213.68
MACD Line 1.73
MACD Signal Line 1.08
MACD Histogram 0.6561
Fundamentals Value
Market Cap 64.36 Million
Num Shares 6.59 Million
EPS -2.01
Price-to-Earnings (P/E) Ratio -4.86
Price-to-Sales 0.00
Price-to-Book 2.02
PEG Ratio -0.02
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.37
Resistance 3 (R3) 12.41 11.58 11.94
Resistance 2 (R2) 11.58 10.92 11.56 11.79
Resistance 1 (R1) 10.67 10.50 10.26 10.63 11.64
Pivot Point 9.84 9.84 9.63 9.82 9.84
Support 1 (S1) 8.93 9.18 8.52 8.89 7.88
Support 2 (S2) 8.10 8.76 8.08 7.73
Support 3 (S3) 7.19 8.10 7.59
Support 4 (S4) 7.15